Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 3
1994 7
1995 1
1996 11
1997 6
1998 8
1999 5
2000 21
2001 12
2002 15
2003 24
2004 23
2005 33
2006 55
2007 60
2008 78
2009 92
2010 100
2011 116
2012 83
2013 100
2014 84
2015 74
2016 51
2017 62
2018 40
2019 54
2020 43
2021 31
2022 6
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

1,157 results

Results by year

Filters applied: . Clear all
Page 1
Teprotumumab for Thyroid-Associated Ophthalmopathy.
Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS. Smith TJ, et al. N Engl J Med. 2017 May 4;376(18):1748-1761. doi: 10.1056/NEJMoa1614949. N Engl J Med. 2017. PMID: 28467880 Free PMC article. Clinical Trial.
2021 update on thyroid-associated ophthalmopathy.
Neag EJ, Smith TJ. Neag EJ, et al. J Endocrinol Invest. 2022 Feb;45(2):235-259. doi: 10.1007/s40618-021-01663-9. Epub 2021 Aug 20. J Endocrinol Invest. 2022. PMID: 34417736 Free PMC article. Review.
Therapeutic Targeting of the IGF Axis.
Osher E, Macaulay VM. Osher E, et al. Cells. 2019 Aug 14;8(8):895. doi: 10.3390/cells8080895. Cells. 2019. PMID: 31416218 Free PMC article. Review.
Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease.
Gulbins A, Horstmann M, Daser A, Flögel U, Oeverhaus M, Bechrakis NE, Banga JP, Keitsch S, Wilker B, Krause G, Hammer GD, Spencer AG, Zeidan R, Eckstein A, Philipp S, Görtz GE. Gulbins A, et al. Front Endocrinol (Lausanne). 2023 Jun 26;14:1211473. doi: 10.3389/fendo.2023.1211473. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37435490 Free PMC article.
Small round cell sarcomas.
Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, Hall KS. Lessnick SL, et al. Semin Oncol. 2009 Aug;36(4):338-46. doi: 10.1053/j.seminoncol.2009.06.006. Semin Oncol. 2009. PMID: 19664494 Review.
Targeting the insulin growth factor receptor 1.
Arnaldez FI, Helman LJ. Arnaldez FI, et al. Hematol Oncol Clin North Am. 2012 Jun;26(3):527-42, vii-viii. doi: 10.1016/j.hoc.2012.01.004. Epub 2012 Feb 28. Hematol Oncol Clin North Am. 2012. PMID: 22520978 Free PMC article. Review.
Minireview: Were the IGF Signaling Inhibitors All Bad?
Beckwith H, Yee D. Beckwith H, et al. Mol Endocrinol. 2015 Nov;29(11):1549-57. doi: 10.1210/me.2015-1157. Epub 2015 Sep 14. Mol Endocrinol. 2015. PMID: 26366975 Free PMC article. Review.
1,157 results